Enteral Feeding Formulas Market Research Report Information By Product (Standard Formulas and Disease-specific Formulas), By Application (Oncology, Critical Care, Neurology, Diabetes, Gastroenterology, and Other Applications), By End User (Hospital, Home Care Agencies, and Hospices, and Other End Users), By Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Global Enteral Feeding Formulas Market Overview

Enteral Feeding Formulas Market Size was valued at USD 5.5 Billion in 2023. The enteral feeding formulas market industry is projected to grow from USD 6.04 Billion in 2024 to USD 15.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.90% during the forecast period (2024 - 2032). The primary market drivers anticipated to propel enteral feeding formula acceptance and accelerate market growth in the coming years are the aging population and the prevalence of chronic diseases, which increase an individual's risk of developing life-threatening conditions like diabetes, cancer, heart failure, and liver failure.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Enteral Feeding Formulas Market Trends

• Rising cancer incidence rates are driving the market growth

Parenteral nutrition is a type of nutritional supplement designed to provide essential nutrients to those with cancer or other diseases that limit the ability to swallow or process food; these supplements have been developed that can be taken orally or by tube fed in their diet have met their nutritional needs they cannot eat or cannot obtain adequate nutrients from a regular diet. With many cancer patients requiring nutritional support, parenteral nutrition is on the rise. As cancer rates increase, the need for enteral nutrition will increase. Furthermore, parenteral nutrition has been shown to reduce infections and other adverse events after radiation, chemotherapy, and surgery in cancer patients, and the result is that many physicians are now recommending enteral nutrition to their patients. The need for enteral formulae with specific ingredients has surged in tandem with the rise in cancer patients. For instance, certain formulae are made to give patients receiving radiation or chemotherapy the nourishment they need. In contrast, other formulas are made to give those with compromised immune systems the nutrition they need. Additionally, new advancements in the sector are anticipated to further stimulate the enteral nutrition formula market CAGR.

The need for enteral feeding formulae has grown dramatically due to the rise in chronic illnesses and the preference for at-home care. Due to home care allowing patients to remain in the comfort of their own homes and offering flexible nutrition delivery, more patients are now choosing it over institutional care. Artificial feeding support through enteral tubes is frequently necessary for long-term diseases such as cancer and gastrointestinal issues. For millions of people who struggle to swallow or are unable to eat on their own, home enteral nutrition helps to improve their quality of life. When compared to hospital stays, families also find it to be more affordable. Because it eases the strain on scarce hospital resources, home healthcare is being promoted by numerous government initiatives. According to World Health Organization data, 71% of deaths worldwide in 2019 were caused by chronic diseases. Long-term dietary support is necessary for several chronic illnesses. In the upcoming years, it is anticipated that the incidence of chronic illness will significantly increase due to the expanding senior population worldwide. The number of persons 60 years of age or older is predicted to more than double, from 900 million worldwide in 2015 to around 2.10 billion in 2050, according to United Nations demographic forecasts. The aging population will further fuel the need for goods for home enteral tube feeding. Thus, driving the enteral feeding formulas market revenue.

Enteral Feeding Formulas Market Segment Insights

Enteral Feeding Formulas Product Insights

The Enteral Feeding Formulas Market segmentation, based on product, includes Standard Formulas and Disease-specific Formulas. In 2023, the standard formulas segment dominated the market. These formulae are a mainstay of enteral feeding, providing a well-balanced combination of calories, vitamins, and macronutrients necessary for those unable to swallow ordinary meals. Patients who need enteral feeding frequently choose standard formulas, particularly if they do not have any special dietary requirements or medical issues that call for a customized formula.

Enteral Feeding Formulas Application Insights

The Enteral Feeding Formulas Market segmentation, based on application, includes Oncology, Critical Care, Neurology, Diabetes, Gastroenterology, and Other Applications. In 2023, the oncology segment dominated the market. The need for enteral feeding formulae among cancer patients is driving this market's expansion. This market's growth is expected to be driven by the increasing popularity of enteral feeding formulas among cancer patients as well as the expanding support and knowledge of the leading companies regarding nutrition for cancer patients.

Enteral Feeding Formulas End User Insights

The Enteral Feeding Formulas Market segmentation, based on end user, includes Hospital, Home Care Agencies and Hospices, and Other End Users. In 2023, the home care agencies segment dominated the market. This notable domination is indicative of the growing trend of enteral nutrition needs being managed at home, with patients receiving customized feeding formulas under the supervision of caretakers or medical professionals.

Enteral Feeding Formulas Distribution Channel Insights

The Enteral Feeding Formulas Market segmentation, based on distribution channel, includes Hospitals, Retail Pharmacies, and Online Pharmacies. The hospitals category generated the most income in 2023. Enteral feeding formulae must be distributed and provided to patients by hospitals, which are the primary care sites for patients in need of this feeding method. In both inpatient and outpatient settings, hospitals frequently use enteral feeding formulas that they acquire in bulk from manufacturers or distributors.

Figure 1: Enteral Feeding Formulas Market, by Distribution Channel, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Enteral Feeding Formulas Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American enteral feeding formulas market area will dominate this market because of the growing number of older adults. The correct implementation of enteral feeding standards for senior individuals and newborn care also serves as a driving force behind the expansion of the market in this particular region. Furthermore, the region's market is anticipated to increase due to the abundance of product makers and the growing elderly population.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.

Figure 2: ENTERAL FEEDING FORMULAS MARKET SHARE BY REGION 2023 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe enteral feeding formulas market accounts for the second-largest market share due to the rapidly aging population and increased rates of chronic diseases and disorders. Additionally, as the senior population grows, there will be a rise in the prevalence of chronic illnesses like diabetes and cancer, which will increase the number of hospital stays for patients. Further, the German enteral feeding formulas market held the largest market share, and the UK enteral feeding formulas market was the fastest growing market in the European region.

The Asia-Pacific Enteral Feeding Formulas Market is expected to grow at the fastest CAGR from 2024 to 2032 because enteral nutrition enhancement efforts and the number of malnutrition cases are growing. Additionally, increasing consumer awareness of the advantages of tube feeding for treating chronic health issues is fueling market expansion in this area throughout the course of the projection period. Moreover, China’s enteral feeding formulas market held the largest market share, and the Indian enteral feeding formulas market was the fastest growing market in the Asia-Pacific region.

Enteral Feeding Formulas Key Market Players & Competitive Insights

Leading market players are investing heavily in research and development in order to expand their product lines, which will help the enteral feeding formulas market grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the internal feeding formulas industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global enteral feeding formulas industry to benefit clients and increase the market sector. In recent years, the enteral feeding formulas industry has offered some of the most significant advantages to medicine. Major players in the enteral feeding formulas market are attempting to increase market demand by investing in research and development operations includes Reckitt Benckiser Group plc. (Mead Johnson), Abbott Laboratories, Danone SA (Nutricia), Fresenius SE & Co. KgaA (Fresenius Kabi AG), B. Braun Melsungen AG, Global Health Product Inc., Meiji Holdings Co. Ltd, Hormel Foods Corporation, Nestle SA, Kate Farms, Victus Inc., and Functional Formularies.

A division of B. Braun SE, B. Braun Melsungen AG (B. Braun) develops, produces, and offers pharmaceuticals, medical services, and medical technology. Infusion solutions and consumables, disinfection products, infusion pumps and systems, suture materials, nutrition and pain management, hip and knee implants, surgical instruments, dialysis equipment and accessories, ostomy care, and wound care products are among the company's main offerings. B. Braun is a provider of systems and products for the fields of intensive care, cardiology, surgery, anesthesia, and extracorporeal blood therapy.

Nutritional items, dairy products, and confections are produced and distributed by Meiji Holdings Co Ltd (Meiji). Gummy candy, yogurt, cheese, ice cream, milk, and chocolates are among the products offered by the company. In addition, the business offers nutritional items, protein supplements, antibacterial agents, vaccinations, and generic pharmaceuticals. It also offers contract development and manufacturing (CDMO) and contract manufacturing (CMO) services. Contract development and manufacturing (CDMO) and contract manufacturing (CMO) are its activities in India. In North America, Europe, and Asia-Pacific, the company oversees and runs production facilities, R&D centers, and sales offices.

Key Companies in the enteral feeding formulas market include

• Reckitt Benckiser Group plc. (Mead Johnson)


• Abbott Laboratories


• Danone SA (Nutricia)


• Fresenius SE & Co. KgaA (Fresenius Kabi AG)


• Braun Melsungen AG


• Global Health Product Inc.


• Meiji Holdings Co. Ltd


• Hormel Foods Corporation


• Nestle SA


• Kate Farms


• Victus Inc.


• Functional Formularies

Enteral Feeding Formulas Industry Developments

September 2022: Novo Holdings, a life science investor, sponsored a Series C fundraising round that saw Kate Farms raise USD 75 million. As a result, Kate Farms will be able to concentrate more on creating novel products, expanding into new markets, and doing plant-based clinical nutrition research.

September 2021: A new line of enteral feeding formulas was introduced by the American manufacturer Abbott. These recipes provide an alternative to conventional methods because they are produced with organic food products and plant-based proteins.

Enteral Feeding Formulas Market Segmentation

Enteral Feeding Formulas Product Outlook

• Standard Formulas


• Disease-specific Formulas

Enteral Feeding Formulas Application Outlook

• Oncology


• Critical Care


• Neurology


• Diabetes


• Gastroenterology


• Other Applications

Enteral Feeding Formulas End User Outlook

• Hospital


• Home Care Agencies and Hospices


• Other End Users

Enteral Feeding Formulas Distribution Channel Outlook

• Hospitals


• Retail Pharmacies


• Online Pharmacies

Enteral Feeding Formulas Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific

• 
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America